Archive · 29 May 2025
Med-Tech Startup Uses Eye Screening to Predict Systemic Diseases
Imagine a doctor could tell you if you might have a heart problem just by looking at your eye!
That's what Remidio, a company in India, is trying to do.
They've created special devices to scan your eyes quickly and easily.
Initially, they focused on detecting eye problems.
Now, they are using this technology to predict other health issues like heart problems, kidney diseases, and even liver cancer.
Because your eyes are connected to the same blood vessels as the rest of your body, the company is able to see clues about your overall health.
Their goal is to make it easier and faster to catch serious illnesses early on, with accessible testing, so people can get help sooner.
Remidio, a med-tech company, is developing eye screening technology to predict systemic diseases.
The company's focus is to identify potential cardiovascular risks, chronic kidney diseases, and liver cancer.
Their devices offer multiple eye tests and are designed for use by various healthcare professionals.
Remidio's technology has been used to screen over 10 million patients globally.
The company integrates AI to offer comprehensive eye screening.
- Who
- Remidio, a med-tech company founded by Dr. Anand Sivaraman.
- What
- Med-tech startup Remidio aims to predict systemic diseases through eye screening.
- When
- Since 2014-15, with initial devices and continuous development since then.
- Where
- India, with devices in use across India, the USA, and Singapore.
- Why
- To enable early detection of systemic diseases like cardiovascular risks and make eye care more accessible.
- Founder
- Dr. Anand Sivaraman
- Initial Focus
- Early detection of eye health issues
- Target Diseases
- Cardiovascular risks, kidney diseases, and liver cancer
- First Device
- Smartphone-based imaging system
- Patients Screened
- More than 10 million
- Countries
- 20